阅读说明：本技术 一种新型降血糖降血压降尿酸降血脂代用茶 (Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat ) 是由 梁成福 于 2019-09-19 设计创作，主要内容包括：本发明公开了一种新型降血糖降血压降尿酸降血脂代用茶,其原料按重量份如下：荷叶1份、山楂1份、茯苓1份、大枣0.5份、桑叶1份、麦芽2份、火麻仁0.5份、甘草0.5份、芦根1份,制备方法,包括如下步骤：选择购进原材料,将原材料清理干净,进行配比；将配比后的原材料进行烘干、消毒、杀菌处理；分别将各组分原料进行粉碎,粉碎后进行筛选,筛选不合格的原料继续进行粉碎处理；采用混合机将各组分原料充分混合；混合后原料加入自动包装机中进行包装,包装袋分为两层,内层为泡茶袋,外层为铝膜,铝膜封口密闭；把包装好的茶包进行装盒。本发明以代用茶的方式,让患者每日当茶饮用,较为方便,而且无副作用,老少皆可饮用,且费用较低。(The invention discloses a novel substitutional tea for reducing blood sugar, blood pressure and uric acid and blood fat, which comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome, and the preparation method comprises the following steps: selecting purchased raw materials, cleaning the raw materials, and proportioning; drying, disinfecting and sterilizing the proportioned raw materials; respectively crushing the raw materials of each component, screening after crushing, and continuously crushing the screened unqualified raw materials; fully mixing the raw materials of each component by adopting a mixer; the mixed raw materials are added into an automatic packaging machine for packaging, the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film seal is closed; and (5) packing the packed tea package into a box. The tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.)

1. A novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat is characterized by comprising the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.

2. The novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat as claimed in claim 1, is characterized in that: the malt 2 parts includes raw malt 1 part and cooked malt 1 part.

3. The preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat as defined in claim 1, which comprises the following steps:

s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;

s2, drying, disinfecting and sterilizing the proportioned raw materials;

s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;

s4, fully mixing the raw materials of the components by a mixer;

s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;

s6, packaging the packaged tea bags.

4. The preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat according to claim 3, which is characterized in that: the net content of each tea bag is 5 g.

Technical Field

The invention belongs to the field of health-care tea, and particularly relates to novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat. Meanwhile, the invention also relates to a preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat.

Background

Hypertension, hyperglycemia (diabetes) and hyperlipidemia. They are "rich diseases" derived from modern society, and may exist alone or be related to each other. Such as: diabetes patients are easy to suffer from hypertension or hyperlipidemia at the same time, the hyperlipidemia is also a main factor for the formation and development of arteriosclerosis, and the blood vessel elasticity of the arteriosclerosis patients is poor to aggravate the increase of blood pressure. Therefore, when any one of the three diseases appears, the "three-high disease" is easily formed in the later period.

Hypertension, one of the most common epidemic diseases in the modern time, early-stage hypertension patients can show symptoms such as headache, dizziness, tinnitus, palpitation, dim eyesight, inattention, hypomnesis, numbness of hands and feet, fatigue, weakness, easy dysphoria and the like, the symptoms are mostly caused by higher nerve dysfunction, and the severity of the symptoms is inconsistent with the degree of increase of blood pressure. The late stage blood pressure is always kept at a high level and is accompanied by the appearance of damaged organs such as brain, heart, kidney and the like. These organ damage can be either direct damage from hypertension or indirectly through accelerated development of atherosclerotic disease. The early stages of these organ damage can be asymptomatic, eventually leading to dysfunction and even failure.

Hyperglycemia, the most common form of hyperglycemia, is diabetes. Diabetes is a chronic and lifelong disease, is a common disease seriously harming human health, and causes abnormal metabolism of nutrients such as carbohydrate, fat, protein and the like in vivo due to relative or absolute deficiency of insulin. The disease can cause various complications, and can cause systemic diseases when serious, which causes people to be disabled, blindness and even death. The symptoms of diabetes are "more than three and one less", i.e. polyuria, polydipsia, polyphagia and weight loss. Patients with hyperglycemia should pay attention to diet control, have low sugar and low salt content, strengthen exercise, and check blood sugar or high blood sugar again after a while, and also consider the drugs for reducing blood sugar.

Hyperlipidemia, hyperlipemia refers to high blood cholesterol or triglyceride or low high density lipoprotein cholesterol, and is called dyslipidemia in modern medicine. If the blood fat is too high, blood viscosity is easily caused, the blood is deposited on the blood vessel wall, atherosclerosis is gradually formed, the blood vessel is gradually blocked, the blood flow is slowed down, and the blood flow is interrupted when the blood flow is serious. The condition can cause coronary heart disease if occurring in the heart, cerebral apoplexy if occurring in the brain, visual deterioration and blindness if blocking the eyeground blood vessel, renal arteriosclerosis and renal failure if occurring in the kidney, limb necrosis and ulceration if occurring in the lower limb, and the like. In addition, hyperlipidemia can cause hypertension, gallstone and pancreatitis, and aggravate hepatitis, senile dementia, etc. For lowering blood lipid, vitamin C tablet, semen Ginkgo soft capsule, liquid calcium, etc. can be taken frequently.

The traditional hypoglycemic and antihypertensive drugs have large side effect and strong drug resistance, the more the drug content is, the higher the blood sugar and blood pressure is, the effective radical cure can not be realized, and complications are easy to cause in the later period and the cost is high.

Disclosure of Invention

The invention aims to provide a novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat, and aims to solve the problems in the background technology.

In order to achieve the purpose, the invention provides the following technical scheme:

a novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.

Preferably, the malt 2 parts includes raw malt 1 part and cooked malt 1 part.

A preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following steps:

s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;

s2, drying, disinfecting and sterilizing the proportioned raw materials;

s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;

s4, fully mixing the raw materials of the components by a mixer;

s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;

s6, packaging the packaged tea bags.

Preferably, the net content of each tea bag is 5 g.

Compared with the prior art, the invention has the beneficial effects that: the tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.

Detailed Description

In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

A novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.

Preferably, the malt 2 parts includes raw malt 1 part and cooked malt 1 part.

A preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following steps:

s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;

s2, drying, disinfecting and sterilizing the proportioned raw materials;

s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;

s4, fully mixing the raw materials of the components by a mixer;

s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;

s6, packaging the packaged tea bags.

Preferably, the net content of each tea bag is 5g, and each box contains 33 bags.

The tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.

The daily dose is 2-4 bags, each bag is boiled with 200ml of water and brewed, drinking is carried out after a few minutes, drinking 6 bags is taken as a course of treatment, and the practice proves that the traditional Chinese medicine can treat both symptoms and root causes and has good effect.

The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.